ストックスクリーナーアプリを入手
167.60
1.19%
-2.01
前日終値:
$169.61
開ける：
$167.26
24時間の取引高:
806.06K
Relative Volume:
0.71
時価総額：
$9.46B
収益：
$763.34M
当期純損益:
$51.40M
株価収益率:
184.50
EPS:
0.9084
ネットキャッシュフロー:
$104.46M
1週間 パフォーマンス:
-4.92%
1か月 パフォーマンス:
+11.90%
6か月 パフォーマンス:
+33.18%
1年 パフォーマンス:
+38.99%
1日の値動き範囲:
$165.00
$169.51
1週間の範囲:
$165.00
$182.57
52週間の値動き範囲:
$100.99
$188.73
Repligen Corp Stock (RGEN) Company Profile
Compare RGEN vs ISRG, BDX, ALC, RMD, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
167.60 | 10.17B | 763.34M | 51.40M | 104.46M | 0.9084 |
ISRG
Intuitive Surgical Inc
|
366.70 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
184.74 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
70.50 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
228.35 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.59 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-17 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-10-01 | 開始されました | HSBC Securities | Buy |
| 2025-09-22 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-07-22 | 再開されました | Stephens | Overweight |
| 2025-06-24 | 開始されました | Barclays | Overweight |
| 2025-04-29 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | 開始されました | Evercore ISI | In-line |
| 2025-02-10 | 開始されました | TD Cowen | Buy |
| 2024-12-17 | 開始されました | Canaccord Genuity | Hold |
| 2024-11-14 | 開始されました | Wolfe Research | Peer Perform |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-26 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-06-18 | 開始されました | Guggenheim | Neutral |
| 2023-12-04 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2023-07-20 | 開始されました | Wells Fargo | Overweight |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-03-28 | 開始されました | The Benchmark Company | Buy |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | 開始されました | UBS | Buy |
| 2021-10-14 | 開始されました | Exane BNP Paribas | Outperform |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-07 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-23 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-11-01 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | 開始されました | SVB Leerink | Outperform |
| 2019-08-28 | 繰り返されました | First Analysis Sec | Outperform |
| 2019-08-23 | 再開されました | Stephens | Overweight |
| 2019-07-22 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | アップグレード | CL King | Neutral → Buy |
| 2018-11-12 | ダウングレード | CL King | Buy → Neutral |
| 2018-09-26 | 開始されました | H.C. Wainwright | Neutral |
| 2017-12-08 | 開始されました | Citigroup | Buy |
| 2017-12-05 | 開始されました | JP Morgan | Overweight |
| 2017-11-13 | 開始されました | CL King | Buy |
| 2017-10-02 | アップグレード | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | 開始されました | William Blair | Outperform |
| 2017-02-13 | アップグレード | Piper Jaffray | Neutral → Overweight |
すべてを表示
Repligen Corp (RGEN) 最新ニュース
Repligen Corp (RGEN) CEO Olivier Loeillot Sells 5,426 Shares - GuruFocus
Repligen (NASDAQ: RGEN) CEO trades shares at $180 under 10b5-1 plan - Stock Titan
LVIP Baron Growth Opportunities Fund's Repligen Corp(RGEN) Holding History - GuruFocus
Repligen rises as investors continue to digest raised 2026 guidance and the BioLife deal - Quiver Quantitative
Repligen (NASDAQ: RGEN) plan covers 5,426-share sale after option exercise - Stock Titan
Repligen Corporation stock hits 52-week high at 176.52 USD By Investing.com - Investing.com South Africa
Repligen Corporation stock hits 52-week high at 176.52 USD - Investing.com
Oppenheimer Asset Management Inc. Purchases New Position in Repligen Corporation $RGEN - MarketBeat
Repligen Corp (RGEN) stake at 3.1% in new T. Rowe Price 13G/A - Stock Titan
Repligen Corporation (RGEN) Stock Forecasts - Yahoo! Finance Canada
Wasatch Advisors LP Buys 346,720 Shares of Repligen Corporation $RGEN - MarketBeat
Assenagon Asset Management S.A. Buys New Shares in Repligen Corporation $RGEN - MarketBeat
Repligen Corporation (RGEN) stock price, news, quote and history - Yahoo Finance UK
Repligen Corporation (NASDAQ:RGEN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Repligen (RGEN) Is Up 16.2% After Revenue Rises But Profitability Compresses In Q2 2026 - Yahoo Finance
Repligen Corp (RGEN) Stock News Today - TradingKey
Repligen Corp (RGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
The Manufacturers Life Insurance Company Decreases Holdings in Repligen Corporation $RGEN - MarketBeat
Is It Too Late to Buy Repligen Corp (RGEN) After 5.8% Rally? GF Value Says Undervalued - GuruFocus
Moody National Bank Trust Division Makes New Investment in Repligen Corporation $RGEN - MarketBeat
California State Teachers Retirement System Raises Holdings in Repligen Corporation $RGEN - MarketBeat
Repligen Submits Form 425 Detailing Proposed Acquisition of BioLife Solutions - Kalkine Media
Repligen Corp (RGEN) Stock Up 4.3% and Still Undervalued -- GF S - GuruFocus
Repligen Earnings: Excellent Profit Margins, China Recovery Underway - Morningstar
Repligen Corporation $RGEN Shares Acquired by Avidity Partners Management LP - MarketBeat
Vanguard Capital Management reports 5% Repligen (RGEN) stake in Schedule 13G - Stock Titan
Repligen Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Wall Street Analysts Believe Repligen (RGEN) Could Rally 25.72%: Here's is How to Trade - Yahoo Finance
Repligen Beats Q2 Earnings Estimates, Raises 2026 View, Stock Up - Barchart.com
Canaccord reiterates Hold on Repligen stock, keeps $145 target By Investing.com - Investing.com Nigeria
Repligen Offers Differentiated Solutions as a Leading Bioprocessing Supplier - Morningstar
Repligen Corp (RGEN) Shares Surge 11.0% -- What GF Score of 87 T - GuruFocus
Repligen Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Repligen Corp (RGEN) Q2 2026 Earnings Call Transcript - AlphaStreet
Is Repligen Corp (RGEN) Undervalued After Q2 Earnings Beat? EPS - GuruFocus
Repligen raises FY2026 adj EPS guidance to $2.03-$2.09 - scanx.trade
Repligen Reports Q2 2026: Revenue $204M, Adjusted EPS $0.54; Raises FY26 Guidance - TradingView
Repligen Q2 2026 revenue rises 12% to $204 million - Quiver Quantitative
Repligen Reports Q2 2026 Revenue Growth, Raises Full-Year Organic Revenue and EPS Guidance - Quiver Quantitative
Repligen: Q2 Earnings Snapshot - Yahoo Finance
Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance - Yahoo Finance
Repligen Corp (RGEN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Repligen Corp (RGEN) Balance Sheet - TradingKey
Repligen Corp (RGEN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Repligen earnings in focus after $1.5B BioLife acquisition By Investing.com - Investing.com South Africa
Repligen Corp (RGEN) Institutional Confidence - TradingKey
RGEN|Repligen Corp|Price:131.960|Chg%:-5.640 - TradingKey
Repligen Corp (RGEN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Repligen (RGEN) Q2 Earnings: What To Expect - Yahoo! Finance Canada
Repligen Corp (RGEN) Cash Flow - TradingKey
ETFs Investing in Repligen Corporation Stocks - TradingView
Repligen Corp (RGEN) 財務データ
収益
当期純利益
現金流量
EPS
Repligen Corp (RGEN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Loeillot Olivier | Chief Executive Officer |
Aug 20 '26 |
Option Exercise |
141.79 |
5,426 |
769,353 |
59,672 |
| Loeillot Olivier | Chief Executive Officer |
Aug 20 '26 |
Sale |
180.00 |
5,426 |
976,680 |
54,246 |
0.76%
1.02%
大文字化:
|
ボリューム (24 時間):